SCHEMBL7877892

SCHEMBL7877892

CNC(N)=NC(=O)c1cc2ccc(OCc3cccc(CN(C)C)c3)cc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 2/20 0.45
CFD P00746 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
MAOB P27338 6/20 0.42
NOS1 P29475 2/20 0.41
NOS2 P35228 1/20 0.41
ACHE P22303 1/20 0.41
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
SRD5A2 P31213 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7877734 0.93 FLT3 (0.46) FLT3CFDMEN1KMT2ARXFP1
SCHEMBL7882351 0.91 CFD (0.44) FLT3CFDMEN1KMT2ARXFP1
SCHEMBL7878034 0.90 FLT3 (0.47) FLT3CFDMEN1KMT2ARXFP1
SCHEMBL7884243 0.89 MEN1 (0.45) FLT3MEN1KMT2ARXFP1NOS1
Hydrochloric Acid SCHEMBL7877491 0.87 FLT3 (0.57) FLT3CFDMEN1KMT2ARXFP1
SCHEMBL7882025 0.86 MEN1 (0.42) FLT3MEN1KMT2ARXFP1MAOB
SCHEMBL7880962 0.86 MAOB (0.37) CFDMAOBNOS1MAOA
SCHEMBL7877709 0.85 FLT3 (0.39) FLT3CFDMEN1KMT2ARXFP1
SCHEMBL7873340 0.85 KMT2A (0.43) FLT3MEN1KMT2ARXFP1PDGFRB
SCHEMBL7877995 0.85 FLT3 (0.47) FLT3CFDMEN1KMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed